Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study

The New England Journal of Medicine
E G LowrieJ A Sargent

Abstract

This report summarizes morbidity in 151 patients in a cooperative trial designed to evaluate the clinical effects of different dialysis prescriptions. Four treatment groups were divided along two dimensions: dialysis treatment time (long or short), and blood urea nitrogen (BUN) concentration averaged with respect to time (TACurea) (high or low). Dietary protein was not restricted. There was no difference in mortality between the groups. Withdrawal of patients from the high-BUN groups for medical reasons was significantly greater than withdrawal from the low-BUN groups. Hospitalization was also greater in the high-BUN groups, but dialysis treatment time had no significant effects. The data indicate that the occurrence of morbid events is affected by the dialysis prescription. Increased morbidity appears to accompany prescriptions associated with a relatively high BUN. Conversely, morbidity may be decreased by prescriptions associated with more efficient removal of urea if the dietary intake of protein and other nutrients is adequate.

References

Sep 1, 1978·The American Journal of Clinical Nutrition·J SargentM Humphreys
Nov 1, 1978·Kidney International·M F BorahM H Humphreys
Jan 1, 1972·Transactions - American Society for Artificial Internal Organs·A L BabbB H Scribner

❮ Previous
Next ❯

Citations

Sep 1, 1993·Muscle & Nerve·L H Phillips, F H Williams
Jan 1, 1995·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·P R KeshaviahP F Emerson
May 8, 2000·Indian Journal of Pediatrics·A Kalia
Dec 17, 2004·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Debbie Gipson, Howard Trachtman
Jul 5, 2006·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Colin T WhiteUNKNOWN Peritoneal Dialysis Working Group
Nov 9, 2010·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Guido FillerRobert M Lindsay
Apr 10, 1993·Lancet·B CharraG Laurent
Mar 26, 2005·Seminars in Nephrology·Manjula Kurella, Glenn M Chertow
Jan 1, 1997·Medical Engineering & Physics·M BurgelmanS Ringoir
Feb 13, 2008·Nature Clinical Practice. Nephrology·Raymond VanholderWim Van Biesen
Nov 26, 2008·Nature Clinical Practice. Nephrology·Charles Chazot, Guillaume Jean
Aug 29, 2012·Nature Reviews. Nephrology·Raymond VanholderWim Van Biesen
Jan 9, 2013·Nature Reviews. Nephrology·Rajnish Mehrotra, Jonathan Himmelfarb
Aug 5, 1999·Kidney International·J Himmelfarb
Nov 26, 1999·Kidney International·G M ChertowE G Lowrie
Dec 14, 1999·Kidney International·A K SalahudeenJ D Bower
Sep 6, 2000·Kidney International·Y P PeiG G Wu
Aug 11, 2000·Kidney International. Supplement·F A GotchM L Keen
Nov 25, 2003·Kidney International·Nigel S KanagasundaramUNKNOWN Project for the Improvement of the Care of Acute Renal Dysfunction (PICARD) Study Group
Mar 13, 2003·Kidney International·Peter G Blake
Nov 12, 1981·The New England Journal of Medicine·R G Luke
Jan 21, 1982·The New England Journal of Medicine·E A Friedman, A P Lundin
Feb 11, 1982·The New England Journal of Medicine·W B SchwartzA P Williams
May 20, 1982·The New England Journal of Medicine·J P BrunoisJ Chanard
Oct 14, 1982·The New England Journal of Medicine·J F De FremontA Fournier
Apr 21, 1983·The New England Journal of Medicine·W E Harmon
Dec 20, 2002·The New England Journal of Medicine·Garabed EknoyanUNKNOWN Hemodialysis (HEMO) Study Group
Aug 2, 2003·The New England Journal of Medicine·Ming TengRavi Thadhani
Nov 26, 2010·The New England Journal of Medicine·Glenn M ChertowAlan S Kliger
Nov 5, 2010·The New England Journal of Medicine·Jonathan Himmelfarb, T Alp Ikizler
Nov 26, 1999·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·G VirgaA Bonadonna
Dec 24, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Michael V RoccoUNKNOWN Hemodialysis (HEMO) Study Group
May 12, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Dominik E UehlingerFelix J Frey
Dec 15, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Alain FicheuxAngel Argilés
Dec 15, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Ercan OkUNKNOWN Long Dialysis Study Group
Jan 26, 2012·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Carlo Basile, Carlo Lomonte
Mar 21, 2012·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Francesca TentoriBruce Robinson
Apr 2, 2013·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Zbylut J TwardowskiAjay K Singh
Apr 2, 2013·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Ajay K SinghMadhukar Misra
Jun 22, 2013·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Andrew Davenport
Apr 14, 2000·Current Opinion in Pediatrics·S Hingorani, S L Watkins
Sep 8, 2005·Southern Medical Journal·Mitchell H Rosner
Dec 24, 2010·Current Opinion in Nephrology and Hypertension·Eduardo Lacson, Michael Lazarus
Jun 1, 1995·British Journal of Pharmacology·R Sorrentino, A Pinto
Oct 24, 2000·Kidney International·A SharmaC Rodd
Jun 18, 2004·Kidney International·Mark UnruhUNKNOWN HEMO Study Group

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.